Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.60 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.58 |
| ▸ | FYN | P06241 | 1/20 | 0.58 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.58 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.58 |
| ▸ | DRD4 | P21917 | 1/20 | 0.58 |
| ▸ | DRD3 | P35462 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 12/20 | 0.57 |
| ▸ | CA12 | O43570 | 11/20 | 0.57 |
| ▸ | CA1 | P00915 | 11/20 | 0.57 |
| ▸ | CA9 | Q16790 | 6/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 7/20 | 0.50 |
| ▸ | CA5A | P35218 | 7/20 | 0.50 |
| ▸ | CA7 | P43166 | 7/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1582590 | 1.00 | CYP2D6 (0.60) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL133580 | 1.00 | CYP2D6 (0.60) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL18652541 | 1.00 | CYP2D6 (0.60) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL13465295 | 1.00 | CYP2D6 (0.60) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL3188307 | 1.00 | CYP2D6 (0.60) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL18880355 | 1.00 | CYP2D6 (0.60) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL12569416 | 1.00 | CYP2D6 (0.60) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL133581 | 1.00 | CYP2D6 (0.60) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL22766232 | 1.00 | CYP2D6 (0.60) | CYP2D6THRBHSD17B10TSHRNR3C1 | |
| SCHEMBL17119468 | 1.00 | CYP2D6 (0.60) | CYP2D6THRBHSD17B10TSHRNR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114773409-B | Preparation method of 2,3,4, 6-tetra-O-acetyl-glucopyranose | 江西艾立斯特生物科技有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-114773409-A | Preparation method of 2,3,4, 6-tetra-O-acetyl-glucopyranose | 江西艾立斯特生物科技有限公司 | 2022-07-22 | — | — | CN | claimed |
| US-20190048202-A1 | METHOD FOR THE PREPARATION OF A COATING COMPRISING OLIGOMERIC ALKYNES | ÉCOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE (EPFL) EPFL-TTO (CH) | 2019-02-14 | — | — | US | claimed |
| WO-2016174266-A2 | METHOD FOR THE PREPARATION OF A COATING | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) EPFL-TTO (CH) | 2016-11-03 | — | — | WO | claimed |
| EP-0867431-B1 | Process for the preparation of azide derivatives | EISAI CO LTD (JP) | 2002-06-05 | — | — | EP | claimed |
| US-5986088-A | Process for the preparation of azide derivatives | EISAI CO., LTD. (JP) | 1999-11-16 | — | — | US | claimed |
| EP-0867431-A1 | Process for the preparation of azide derivatives | Eisai Chemical Co., Ltd. (JP) | 1998-09-30 | — | — | EP | claimed |
| EP-0511917-B1 | Glycosylated prodrugs, process for their preparation and uses thereof | HOECHST SA LAB (FR) | 1996-10-23 | — | — | EP | claimed |
| WO-1992019639-A1 | GLYCOSYLATED PRODRUGS, METHOD OF PREPARATION AND USE | LABORATOIRES HOECHST (FR) | 1992-11-12 | — | — | WO | claimed |
| EP-0511917-A1 | Glycosylated prodrugs, process for their preparation and uses thereof | LABORATOIRES HOECHST S.A. (FR) | 1992-11-04 | — | — | EP | claimed |
| US-20260109721-A1 | IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON: SYNTHESIS AND LNP FORMULATION | ALDEXCHEM KFT (HU) | 2026-04-23 | — | — | US | disclosed |
| US-12552823-B2 | Glucosamine derivatives and pharmaceutical uses thereof | Risen (Suzhou) Pharma Tech Co., Ltd. (CN) | 2026-02-17 | — | — | US | disclosed |
| US-20260022140-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | GLYCOSCIENCE, S.L. (ES) | 2026-01-22 | — | — | US | disclosed |
| US-20260008793-A1 | IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON | ALDEXCHEM KFT (HU) | 2026-01-08 | — | — | US | disclosed |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | GLYCOSCIENCE, S.L. (ES) | 2025-12-30 | — | — | US | disclosed |
| US-4868289-A | INTERFERE WITH BINDING OF VIRUSES AND BACTERIA, USEFUL AGAINST INFECTION AND FOR DIAGNOSIS | SYMBICOM AKTIEBOLAG (SE) | 1989-09-19 | — | — | US | disclosed |
| US-4855417-A | Anomeric deacetylation | YEDA RESEARCH AND DEVELOPMENT COMPANY LTD (IL) | 1989-08-08 | — | — | US | disclosed |
| US-4792615-A | HYDROLYSIS OF A-DIHYDROPOLYPRENYL DICHLOROPHOSPHATE WITH ALKALI OR ALKALINE EARTH METAL HYDROXIDE; POLYISOPRENE | NAKAGAWA NAOSHI (JP) | 1988-12-20 | — | — | US | disclosed |
| EP-0208749-A1 | GLYCOSIDIC DERIVATIVES. | SYNTEK AB (SE) | 1987-01-21 | — | — | EP | disclosed |
| WO-1986004065-A1 | GLYCOSIDIC DERIVATIVES | SYN-TEK AB (SE) | 1986-07-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022140-A1 | 3'-KETOGLYCOSIDE COMPOUND FOR THE SLOW RELEASE OF A VOLATILE ALCOHOL | GPR35, DPY30, ERG28 | CYP2D6 3066/4885THRB 3043/4885HSD17B10 1795/4885 |
| US-12552823-B2 | Glucosamine derivatives and pharmaceutical uses thereof | SOST, FUT6, SLC5A1 | CYP2D6 1419/4885THRB 819/4885HSD17B10 4261/4885 |
| US-20260008793-A1 | IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON | SGMS1, SGMS2, AGO2 | CYP2D6 4447/4885THRB 3687/4885HSD17B10 2337/4885 |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | EBP, MGAT1, MGAT3 | CYP2D6 2139/4885THRB 437/4885HSD17B10 700/4885 |
| US-20260109721-A1 | IONIZABLE CATIONIC LIPIDS INCORPORATING SILICON: SYNTHESIS AND LNP FORMULATION | SGMS1, SGMS2, AGO2 | CYP2D6 4702/4885THRB 2565/4885HSD17B10 3336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.